Medical therapy of coronary artery disease after percutaneous intervention

Current Opinion in Pharmacology

Volumn 13, Issue 2, 2013, Pages 287-293

  Kurz, David J ^a   Eberli, Franz R ^a  

^a TRIEMLI HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS CLOPIDOGREL; ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; CLOPIDOGREL; DABIGATRAN; EVEROLIMUS; OMEPRAZOLE; PACLITAXEL; POLYMER; PRASUGREL; RAPAMYCIN; RIVAROXABAN; TICAGRELOR; TICLOPIDINE; UMIROLIMUS;

ACUTE CORONARY SYNDROME; AGRANULOCYTOSIS; BARE METAL STENT; BLEEDING; CLINICAL EFFECTIVENESS; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG DELIVERY SYSTEM; DRUG DOSE INCREASE; DRUG ELUTING STENT; DRUG MECHANISM; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG THERAPY; DRUG WITHDRAWAL; GASTROINTESTINAL HEMORRHAGE; HEART MUSCLE ISCHEMIA; HUMAN; IN-STENT RESTENOSIS; LOADING DRUG DOSE; NONHUMAN; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; SHUNT THROMBOSIS; STENT THROMBOSIS; TREATMENT DURATION; TREATMENT RESPONSE;

CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; THROMBOSIS;

EID: 84879410087     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2013.01.011     Document Type: Review

References (60)

1. K.A. Fox, T.C. Clayton, P. Damman, S.J. Pocock, R.J. de Winter, J.G. Tijssen, B. Lagerqvist, and L. Wallentin Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data J Am Coll Cardiol 55 2010 2435 2445
2. G.N. Levine, E.R. Bates, J.C. Blankenship, S.R. Bailey, J.A. Bittl, B. Cercek, C.E. Chambers, S.G. Ellis, R.A. Guyton, and S.M. Hollenberg 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions Circulation 124 2011 e574 e651
3. W. Wijns, P. Kolh, N. Danchin, M.C. Di, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, and J. Knuuti Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
4. A. Undas, K.E. Brummel-Ziedins, and K.G. Mann Statins and blood coagulation Arterioscler Thromb Vasc Biol 25 2005 287 294 (Pubitemid 40189147)
5. S.C. Smith Jr., E.J. Benjamin, R.O. Bonow, L.T. Braun, M.A. Creager, B.A. Franklin, R.J. Gibbons, S.M. Grundy, L.F. Hiratzka, and D.W. Jones AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation Circulation 124 2011 2458 2473
6. G.D. Curfman, S. Morrissey, J.A. Jarcho, and J.M. Drazen Drug-eluting coronary stents - promise and uncertainty N Engl J Med 356 2007 1059 1060 (Pubitemid 46380238)
7. G.W. Stone, J.W. Moses, S.G. Ellis, J. Schofer, K.D. Dawkins, M.C. Morice, A. Colombo, E. Schampaert, E. Grube, and A.J. Kirtane Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008 (Pubitemid 46376800)
8. P. Wenaweser, C. Rey, F.R. Eberli, M. Togni, D. Tuller, S. Locher, A. Remondino, C. Seiler, O.M. Hess, B. Meier, and S. Windecker Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome Eur Heart J 26 2005 1180 1187 (Pubitemid 40863124)
9. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, and P. Vranckx Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
10. G. Guagliumi, V. Sirbu, G. Musumeci, R. Gerber, G. Biondi-Zoccai, H. Ikejima, E. Ladich, N. Lortkipanidze, A. Matiashvili, and O. Valsecchi Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging JACC Cardiovasc Interv 5 2012 12 20
11. F. Otsuka, A.V. Finn, S.K. Yazdani, M. Nakano, F.D. Kolodgie, and R. Virmani The importance of the endothelium in atherothrombosis and coronary stenting Nat Rev Cardiol 9 2012 439 453
12. S.J. Park, S.J. Kang, R. Virmani, M. Nakano, and Y. Ueda In-stent neoatherosclerosis: a final common pathway of late stent failure J Am Coll Cardiol 59 2012 2051 2057
13. S. Cook, P. Wenaweser, M. Togni, M. Billinger, C. Morger, C. Seiler, R. Vogel, O. Hess, B. Meier, and S. Windecker Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation Circulation 115 2007 2426 2434 (Pubitemid 46717965)
14. P.W. Serruys, B.H. Strauss, K.J. Beatt, M.E. Bertrand, J. Puel, A.F. Rickards, B. Meier, J.J. Goy, P. Vogt, and L. Kappenberger Angiographic follow-up after placement of a self-expanding coronary-artery stent N Engl J Med 324 1991 13 17
15. M.E. Bertrand, V. Legrand, J. Boland, E. Fleck, J. Bonnier, H. Emmanuelson, M. Vrolix, L. Missault, S. Chierchia, and M. Casaccia Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study Circulation 98 1998 1597 1603 (Pubitemid 28500380)
16. M.B. Leon, D.S. Baim, J.J. Popma, P.C. Gordon, D.E. Cutlip, K.K. Ho, A. Giambartolomei, D.J. Diver, D.M. Lasorda, and D.O. Williams A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators N Engl J Med 339 1998 1665 1671 (Pubitemid 28550691)
17. A. Schomig, F.J. Neumann, A. Kastrati, H. Schuhlen, R. Blasini, M. Hadamitzky, H. Walter, E.M. Zitzmann-Roth, G. Richardt, and E. Alt A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents N Engl J Med 334 1996 1084 1089 (Pubitemid 26120185)
18. P. Urban, C. Macaya, H.J. Rupprecht, F. Kiemeneij, H. Emanuelsson, A. Fontanelli, M. Pieper, T. Wesseling, and L. Sagnard Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS) Circulation 98 1998 2126 2132 (Pubitemid 28527471)
19. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients Br Med J 324 2002 71 86
20. M.E. Bertrand, H.J. Rupprecht, P. Urban, and A.H. Gershlick Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS) Circulation 102 2000 624 629 (Pubitemid 30640661)
21. J.L. Mega, S.L. Close, S.D. Wiviott, L. Shen, R.D. Hockett, J.T. Brandt, J.R. Walker, E.M. Antman, W. Macias, E. Braunwald, and M.S. Sabatine Cytochrome p-450 polymorphisms and response to clopidogrel N Engl J Med 360 2009 354 362
22. S.R. Mehta, J.F. Tanguay, J.W. Eikelboom, S.S. Jolly, C.D. Joyner, C.B. Granger, D.P. Faxon, H.J. Rupprecht, A. Budaj, and A. Avezum Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial Lancet 376 2010 1233 1243
23. M.J. Price, P.B. Berger, P.S. Teirstein, J.F. Tanguay, D.J. Angiolillo, D. Spriggs, S. Puri, M. Robbins, K.N. Garratt, and O.F. Bertrand Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial J Am Med Assoc 305 2011 1097 1105
24. J.P. Collet, T. Cuisset, G. Range, G. Cayla, S. Elhadad, C. Pouillot, P. Henry, P. Motreff, D. Carrie, and Z. Boueri Bedside monitoring to adjust antiplatelet therapy for coronary stenting N Engl J Med 367 2012 2100 2109
25. G. Sardella, S. Calcagno, M. Mancone, R. Palmirotta, L. Lucisano, E. Canali, R.E. Stio, M. Pennacchi, R.A. Di, and G. Benedetti Pharmacodynamic effect of switching therapy in patients with high on-treatment platelet reactivity and genotype variation with high clopidogrel dose versus prasugrel: the RESET GENE trial Circ Cardiovasc Interv 5 2012 698 704
26. P.A. Gurbel, D. Erlinge, E.M. Ohman, B. Neely, M. Neely, S.G. Goodman, K. Huber, M.Y. Chan, J.H. Cornel, and E. Brown Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy J Am Med Assoc 308 2012 1785 1794
27. M.T. Roe, P.W. Armstrong, K.A. Fox, H.D. White, D. Prabhakaran, S.G. Goodman, J.H. Cornel, D.L. Bhatt, P. Clemmensen, and F. Martinez Prasugrel versus clopidogrel for acute coronary syndromes without revascularization N Engl J Med 367 2012 1297 1309
28. S.R. Steinhubl, P.B. Berger, J.T. Mann III, E.T. Fry, A. DeLago, C. Wilmer, and E.J. Topol Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial J Am Med Assoc 288 2002 2411 2420 (Pubitemid 35340537)
29. M. Pfisterer, H.P. Brunner-La Rocca, P.T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, and C. Kaiser Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents J Am Coll Cardiol 48 2006 2584 2591 (Pubitemid 44881238)
30. B. Lagerqvist, S.K. James, U. Stenestrand, J. Lindback, T. Nilsson, and L. Wallentin Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden N Engl J Med 356 2007 1009 1019 (Pubitemid 46376801)
31. C. Stettler, S. Wandel, S. Allemann, A. Kastrati, M.C. Morice, A. Schomig, M.E. Pfisterer, G.W. Stone, M.B. Leon, and J.S. de Lezo Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948 (Pubitemid 47393576)
32. C. Kaiser, S. Galatius, P. Erne, F. Eberli, H. Alber, H. Rickli, G. Pedrazzini, B. Hornig, O. Bertel, and P. Bonetti Drug-eluting versus bare-metal stents in large coronary arteries N Engl J Med 363 2010 2310 2319
33. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029 (Pubitemid 46376802)
34. G.W. Stone, A.J. Lansky, S.J. Pocock, B.J. Gersh, G. Dangas, S.C. Wong, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, and B.R. Brodie Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction N Engl J Med 360 2009 1946 1959
35. G.G. Stefanini, R.A. Byrne, P.W. Serruys, W.A. de, B. Meier, S. Massberg, P. Juni, A. Schomig, S. Windecker, and A. Kastrati Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials Eur Heart J 33 2012 1214 1222
36. C.L. Grines, R.O. Bonow, D.E. Casey Jr., T.J. Gardner, P.B. Lockhart, D.J. Moliterno, P. O'Gara, and P. Whitlow Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians J Am Coll Cardiol 49 2007 734 739 (Pubitemid 46210116)
37. F. Airoldi, A. Colombo, N. Morici, A. Latib, J. Cosgrave, L. Buellesfeld, E. Bonizzoni, M. Carlino, U. Gerckens, and C. Godino Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment Circulation 116 2007 745 754 (Pubitemid 47255992)
38. S.J. Park, D.W. Park, Y.H. Kim, S.J. Kang, S.W. Lee, C.W. Lee, K.H. Han, S.W. Park, S.C. Yun, and S.G. Lee Duration of dual antiplatelet therapy after implantation of drug-eluting stents N Engl J Med 362 2010 1374 1382
39. M. Valgimigli, G. Campo, M. Monti, P. Vranckx, G. Percoco, C. Tumscitz, F. Castriota, F. Colombo, M. Tebaldi, and G. Fuca Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial Circulation 125 2012 2015 2026
40. H.C. Gwon, J.Y. Hahn, K.W. Park, Y.B. Song, I.H. Chae, D.S. Lim, K.R. Han, J.H. Choi, S.H. Choi, and H.J. Kang Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study Circulation 125 2012 505 513
41. B.K. Kim, M.K. Hong, D.H. Shin, C.M. Nam, J.S. Kim, Y.G. Ko, D. Choi, T.S. Kang, B.E. Park, and W.C. Kang A new strategy for discontinuation of dual antiplatelet therapy: the RESET trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation) J Am Coll Cardiol 60 2012 1340 1348
42. S.R. Mehta, S. Yusuf, R.J. Peters, M.E. Bertrand, B.S. Lewis, M.K. Natarajan, K. Malmberg, H. Rupprecht, F. Zhao, and S. Chrolavicius Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533 (Pubitemid 32772726)
43. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
44. P. Wenaweser, J. Daemen, M. Zwahlen, D.R. van, P. Juni, S. Vaina, G. Hellige, K. Tsuchida, C. Morger, and E. Boersma Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-Year results from a large 2-institutional cohort study J Am Coll Cardiol 52 2008 1134 1140
45. A. Bellemain-Appaix, D. Brieger, F. Beygui, J. Silvain, A. Pena, G. Cayla, O. Barthelemy, J.P. Collet, and G. Montalescot New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis J Am Coll Cardiol 56 2010 1542 1551
46. S. Husted, H. Emanuelsson, S. Heptinstall, P.M. Sandset, M. Wickens, and G. Peters Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin Eur Heart J 27 2006 1038 1047
47. T. Jernberg, C.D. Payne, K.J. Winters, C. Darstein, J.T. Brandt, J.A. Jakubowski, H. Naganuma, A. Siegbahn, and L. Wallentin Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease Eur Heart J 27 2006 1166 1173
48. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, S. Gottlieb, F.J. Neumann, D. Ardissino, S.S. De, and S.A. Murphy Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
49. S.D. Wiviott, E. Braunwald, C.H. McCabe, I. Horvath, M. Keltai, J.P. Herrman, F. Van de Werf, W.E. Downey, B.M. Scirica, S.A. Murphy, and E.M. Antman Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial Lancet 371 2008 1353 1363
50. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, and H. Katus Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
51. C.P. Cannon, R.A. Harrington, S. James, D. Ardissino, R.C. Becker, H. Emanuelsson, S. Husted, H. Katus, M. Keltai, and N.S. Khurmi Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study Lancet 375 2010 283 293
52. P.M. Ho, T.M. Maddox, L. Wang, S.D. Fihn, R.L. Jesse, E.D. Peterson, and J.S. Rumsfeld Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome J Am Med Assoc 301 2009 937 944
53. D.L. Bhatt, B.L. Cryer, C.F. Contant, M. Cohen, A. Lanas, T.J. Schnitzer, T.L. Shook, P. Lapuerta, M.A. Goldsmith, and L. Laine Clopidogrel with or without omeprazole in coronary artery disease N Engl J Med 363 2010 1909 1917
54. G.Y. Lip, K. Huber, F. Andreotti, H. Arnesen, J.K. Airaksinen, T. Cuisset, P. Kirchhof, and F. Marin Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary - a consensus document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 31 2010 1311 1318
55. W. Dewilde WOEST first randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI) Presented at the European Society of Cardiology (ESC) Congress Munich, Germany, August 25-29 2012
56. H.P. Bestehorn, F.J. Neumann, H.J. Buttner, P. Betz, P. Sturzenhofecker, H.E. von, A. Verdun, L. Levai, J.P. Monassier, and H. Roskamm Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) trial J Am Coll Cardiol 43 2004 2160 2165 (Pubitemid 38765106)
57. T.C. Woods, and A.R. Marks Drug-eluting stents Annu Rev Med 55 2004 169 178 (Pubitemid 38316721)
58. J.W. Moses, M.B. Leon, J.J. Popma, P.J. Fitzgerald, D.R. Holmes, C. O'Shaughnessy, R.P. Caputo, D.J. Kereiakes, D.O. Williams, and P.S. Teirstein Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323 (Pubitemid 37186209)
59. S. Windecker, A. Remondino, F.R. Eberli, P. Juni, L. Raber, P. Wenaweser, M. Togni, M. Billinger, D. Tuller, and C. Seiler Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization N Engl J Med 353 2005 653 662 (Pubitemid 41175673)
60. A.S. Puranik, E.R. Dawson, and N.A. Peppas Recent advances in drug eluting stents Int J Pharm 441 2013 665 679